儿茶酚胺敏感性多形性室性心动过速的精准医学:JACC焦点研讨会5/5
本文是JACC精准医学焦点研讨会系列的第5篇,聚焦儿茶酚胺敏感性多形性室性心动过速(CPVT)。文章提出CPVT可分为典型与非典型两种形式,二者存在一定重叠,但由不同基因改变所致,可能具有不同作用机制和表型特征。识别这些不同形式及其病因和机制,是实施针对特定基因缺陷的精准医学新疗法的重要一步。
要点
- CPVT可分为典型与非典型两种形式,二者临床表型存在重叠。
- 典型与非典型CPVT由不同基因改变所致,可能机制不同。
- 识别CPVT不同形式及机制有助于针对特定基因缺陷的精准治疗。
核心结论
- CPVT可表现为典型或非典型形式,二者由不同基因改变所致并可能具有不同机制和表型。
- 识别CPVT的不同形式及其病因和机制是实现针对特定基因缺陷精准治疗的重要步骤。
研究设计与样本
- 本文为JACC精准医学焦点研讨会系列第5篇,专题聚焦CPVT的精准医学机会。
主要发现
- 典型与非典型CPVT之间存在一定程度重叠,但由不同潜在遗传改变引起。
- 两种形式可能表现出不同的作用机制和不同的表型特征。
临床怎么用
- 临床应识别CPVT的典型与非典型形式,并考虑其不同的遗传病因和机制。
- 基于基因缺陷的精准医学方法有望为CPVT患者定制新型疗法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In this final of a 5-part Focus Seminar series on precision medicine, we focus on catecholaminergic polymorphic ventricular tachycardia (CPVT). This focus on CPVT allows us to take a "deep dive" and explore the full extent of the precision medicine opportunities for a single cardiovascular condition at a level that was not possible in the preceding articles. As a new paradigm presented in this article, it has become clear that CPVT can occur as either a typical or atypical form. Although there is a degree of overlap between the typical and atypical forms, it is notable that they arise due to different underlying genetic changes, likely exhibiting differing mechanisms of action, and presenting with different phenotypic features. The recognition of these differing forms of CPVT and their different etiologies and mechanisms is an important step toward implementing rapidly emerging precision medicine approaches that will tailor novel therapies to specific gene defects.
引用
- Priori SG, Mazzanti A, Santiago DJ, et al. Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5. J Am Coll Cardiol. 2021. PMID: 34016269. doi:10.1016/j.jacc.2020.12.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。